Market Highlights
Diabetes mellitus type 2 is a
metabolic disorder, characterized by high blood sugar, relative lack of
insulin, and insulin resistance. The common symptoms of type 2 diabetes include
constant hunger, itchy skin, weight loss, frequent urination, and others.
A number of factors such as
increasing technological advancements, rising prevalence of disease, related
comorbidities, unmet medical needs, improvement in the regulatory framework,
and increasing government assistance, are few factors propelling the growth of
the global type 2 diabetes mellitus treatment market.
However, the high cost of treatment,
side-effects of available treatment options, and poor healthcare system in low
or middle-income countries may hamper the growth of the market.
It is estimated that the type
2 diabetes mellitus treatment market size is expected to grow at a CAGR
8.0% during the forecast period of 2017-2023.
Regional Analysis
The Americas dominate the type 2
diabetes mellitus treatment market owing to the presence of patient population,
a well-developed technology, high healthcare expenditure, and the presence of
the leading players. Due to the rising prevalence of diabetes, various
companies, and government associations are actively participating in improving
diabetes care. For instance, The Merck Foundation provided funding of around
USD 10,000,000 for the projects designed to improve diabetes care in the United
States.
Europe holds the second position in
the type 2 diabetes mellitus treatment market. It is expected that the
government support towards research & development expenditure and
amendments in reimbursement policies in the healthcare is likely to drive the
European market. As per the guidelines suggested by German maternity, every
pregnant woman can undergo glucose challenge test for the early diagnosis of Gestational
diabetes mellitus, and the charges for the test are completely covered by
women’s health insurance.
Asia Pacific is the fastest growing
type 2 diabetes mellitus treatment market owing to a huge patient pool,
increasing demand, and development in healthcare technology.
The Middle East & Africa holds
the lowest share of the global market due to low development, lack of technical
knowledge, and poor medical facilities.
Segmentation
The global type 2 diabetes mellitus
treatment market is segmented on the basis of treatment and end user.
On the basis of the treatment, the
market is classified as a drug class and devices. The drug class is further
segmented into insulin, sensitizers, SGLT-2 inhibitors, alpha-glucosidase
inhibitors, secretagogues, peptide analogs, others. The sub-segment of
sensitizers includes thiazolidinediones and biguanides. The sub-segment of
secretagogues includes sulfonylureas and non-sulfonylureas. The devices market
is further segmented into blood glucose monitoring devices and insulin delivery
devices. The sub-segment of blood glucose monitoring devices includes testing
strips, lancets, continuous glucose monitors, self-monitoring blood glucose
meters, and others. The sub-segment of insulin delivery devices includes
insulin pens, insulin pumps, insulin syringes, and insulin jet injectors.
On the basis of the end user, the
market is segmented into hospitals, clinics, diagnostic centers, drug stores,
pharmacies, and others.
Key Players
Some of key the players in the
global type 2 diabetes mellitus treatment market are Abbott Laboratories, Acon
Laboratories, Inc., Adocia, Akros Pharma, Amgen, AstraZeneca, Bayer AG, Becton,
Dickinson and Company, Biocon, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly,
Novartis & Co., Novo Nordisk, Peptron, Pfizer, Roche Diagnostics Ltd.,
Sanofi, Sunpharma, Takeda Pharmaceuticals, and others.
Access Report Details @ https://www.marketresearchfuture.com/reports/type-2-diabetes-mellitus-treatment-market-5669
About Market Research
Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by Components, Application, Logistics and market players for
global, regional, and country level market segments, enable our clients to see
more, know more, and do more, which help to answer all their most important
questions.
In order to stay updated with technology and work process of
the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of
researchers are studying Covid19 and its impact on various industry verticals
and wherever required we will be considering covid19 footprints for a better
analysis of markets and industries. Cordially get in touch for more details.
